Zynerbia Pharmaceuticals Inc. (NASDAQ: ZYNE) has appointed Albert Parker as its Chief Legal Officer and Corporate Sectary to replace Suzanne Hanlon, who is retiring at the...
InMed Pharmaceuticals Inc. (NASDAQ: INM) has announced its financial results for fiscal Q2 2022 for the quarter ended December 31, 2021. InMed finalized BayMedica acquisition During...
InMed Pharmaceuticals Inc. (NASDAQ: INM) has announced fiscal Q1 2022 financial results for the quarter ended September 30, 2021. InMed witnessed positive momentum across all its...
InMed Pharmaceuticals Inc (NASDAQ:INM) achieved several risk-mitigating and value-adding milestones in IntegraSyn production approach and therapeutic programs. Eric A. Adams, CEO of InMed, said the company...